Bone strength is reduced in a neonatal androgenized rat model

Anzai, 2017, Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats, Sci. Rep., 7, 13167, 10.1038/s41598-017-13451-8 Burch, 2021, Relationship between circulating metabolic hormones and their central receptors during Ovariectomy-induced weight gain in rats, Front. Physiol., 12 Domazetovic, 2017, Oxidative stress in bone remodeling: role of antioxidants, Clin. Cases Miner. Bone Metab., 14, 209, 10.11138/ccmbm/2017.14.1.209 Iantomasi, 2023, Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs, Int. J. Mol. Sci., 24, 10.3390/ijms24043772 Kalyan, 2017, Competing factors link to bone health in polycystic ovary syndrome: chronic low-grade inflammation takes a toll, Sci. Rep., 7, 3432, 10.1038/s41598-017-03685-x Karadag, 2017, Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients, Gynecol. Endocrinol., 33, 234, 10.1080/09513590.2016.1250256 Kassanos, 2010, Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study, Hum. Reprod., 25, 2107, 10.1093/humrep/deq149 Katulski, 2014, Bone mineral density in women with polycystic ovary syndrome, J. Endocrinol. Investig., 37, 1219, 10.1007/s40618-014-0175-5 Macari, 2015, Oestrogen regulates bone resorption and cytokine production in the maxillae of female mice, Arch. Oral Biol., 60, 333, 10.1016/j.archoralbio.2014.11.010 Marcondes, 2015, Differences in neonatal exposure to estradiol or testosterone on ovarian function and hormonal levels, Gen. Comp. Endocrinol., 212, 28, 10.1016/j.ygcen.2015.01.006 McCartney Ch, 2016, Polycystic ovary syndrome, N. Engl. J. Med., 375, 1398 Montalvany-Antonucci, 2018, High-fat diet disrupts bone remodeling by inducing local and systemic alterations, J. Nutr. Biochem., 59, 93, 10.1016/j.jnutbio.2018.06.006 Monteiro, 2016, Effect of treatment with simvastatin on bone microarchitecture of the femoral head in an osteoporosis animal model, Microsc. Res. Tech., 79, 684, 10.1002/jemt.22682 Mujica, 2021, Trabecular bone is increased in a rat model of polycystic ovary syndrome, Exp. Clin. Endocrinol. Diabetes, 129, 757, 10.1055/a-1284-5491 Nebot, 2022, Combination of caloric restriction and a mixed training protocol as an effective strategy to counteract the deleterious effects in trabecular bone microarchitecture caused by a diet-induced obesity in Sprague Dawley rats, Nutrients, 14, 10.3390/nu14183672 Ota, 1983, Endocrinological and histological aspects of the process of polycystic ovary formation in the rat treated with testosterone propionate, Tohoku J. Exp. Med., 140, 121, 10.1620/tjem.140.121 Paccou, 2016, Bone microarchitecture in men and women with diabetes: the importance of cortical porosity, Calcif. Tissue Int., 98, 465, 10.1007/s00223-015-0100-8 Padmanabhan, 2013, Animal models of the polycystic ovary syndrome phenotype, Steroids, 78, 734, 10.1016/j.steroids.2013.05.004 Pei, 2021, A potential participant in type 2 diabetes bone fragility: TIMP-1 at sites of osteocyte lacunar-Canalicular system, Diabetes Metab. Syndr. Obes., 14, 4903, 10.2147/DMSO.S345081 Pinilla, 2002, Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat, J. Endocrinol., 172, 441, 10.1677/joe.0.1720441 Piovezan, 2019, Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis, Hum. Reprod. Update, 25, 633, 10.1093/humupd/dmz020 Rubin, 2016, Fracture risk is decreased in women with polycystic ovary syndrome: a register-based and population-based cohort study, J. Bone Miner. Res., 31, 709, 10.1002/jbmr.2737 Samelson, 2018, Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study, J. Bone Miner. Res., 33, 54, 10.1002/jbmr.3240 Schmidt, 2012, Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study, Clin. Endocrinol., 77, 207, 10.1111/j.1365-2265.2012.04378.x Serrano Mujica, 2017, The impact of postnatal leuprolide acetate treatment on reproductive characteristics in a rodent model of polycystic ovary syndrome, Mol. Cell. Endocrinol., 442, 125, 10.1016/j.mce.2016.12.015 Serrano Mujica, 2021, Ovariectomy improves metabolic and oxidative stress marker disruption in androgenized rats: possible approach to postmenopausal polycystic ovary syndrome, Metab. Syndr. Relat. Disord., 19, 312, 10.1089/met.2020.0077 Sir-Petermann, 2016, Metabolic features across the female life span in women with PCOS, Curr. Pharm. Des., 22, 5515, 10.2174/1381612822666160722100534 Stener-Victorin, 2020, Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome, Endocr. Rev., 41, 10.1210/endrev/bnaa010 Stuermer, 2009, Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats, World J. Urol., 27, 547, 10.1007/s00345-009-0373-5 Sun, 2013, Effects of electroacupuncture of “Guanyuan” (CV 4)-“Zhongji” (CV 3) on ovarian P450 arom and P450c 17alpha expression and relevant sex hormone levels in rats with polycystic ovary syndrome, Zhen Ci Yan Jiu, 38, 465 Tamura, 2005, Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome, Fertil. Steril., 84, 1277, 10.1016/j.fertnstert.2005.06.017 Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Hum. Reprod., 33, 1602, 10.1093/humrep/dey256 Turner, 1990, Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats, Am. J. Phys., 258, E673 Tyndall, 2012, Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats, Reproduction, 143, 21, 10.1530/REP-11-0239 Vestergaard, 2007, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis, Osteoporos. Int., 18, 427, 10.1007/s00198-006-0253-4 Walters, 2012, Rodent models for human polycystic ovary syndrome, Biol. Reprod., 86, 149, 10.1095/biolreprod.111.097808 Yanagihara, 2015, Effects of long-term administration of omeprazole on bone mineral density and the mechanical properties of the bone, Rev. Bras. Ortop., 50, 232, 10.1016/j.rbo.2014.05.012 Yang, 2018, Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study, J. Bone Miner. Metab., 36, 741, 10.1007/s00774-017-0894-8 Yarrow, 2008, Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats, Am. J. Physiol. Endocrinol. Metab., 295, E1213, 10.1152/ajpendo.90640.2008 Yu, 2015, Defects in cortical microarchitecture among African-American women with type 2 diabetes, Osteoporos. Int., 26, 673, 10.1007/s00198-014-2927-7